Literature DB >> 26457913

Presentation and management of post-allogeneic transplantation EBV-positive mucocutaneous ulcer.

A A Nelson1, A M Harrington2, S Kroft2, M A Dahar3, M Hamadani4, B Dhakal4.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26457913     DOI： 10.1038/bmt.2015.245

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  9 in total

1.  Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.

Authors:  R E Curtis; L B Travis; P A Rowlings; G Socié; D W Kingma; P M Banks; E S Jaffe; G E Sale; M M Horowitz; R P Witherspoon; D A Shriner; D J Weisdorf; H J Kolb; K M Sullivan; K A Sobocinski; R P Gale; R N Hoover; J F Fraumeni; H J Deeg
Journal:  Blood       Date:  1999-10-01       Impact factor: 22.113

2.  New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors.

Authors:  K Scott Baker; Todd E DeFor; Linda J Burns; Norma K C Ramsay; Joseph P Neglia; Leslie L Robison
Journal:  J Clin Oncol       Date:  2003-04-01       Impact factor: 44.544

3.  EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression.

Authors:  Stefan D Dojcinov; Girish Venkataraman; Mark Raffeld; Stefania Pittaluga; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

4.  Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma.

Authors:  Stefan D Dojcinov; Girish Venkataraman; Stefania Pittaluga; Iwona Wlodarska; Jeffrey A Schrager; Mark Raffeld; Robert K Hills; Elaine S Jaffe
Journal:  Blood       Date:  2011-03-08       Impact factor: 22.113

5.  Epstein Barr virus-positive mucocutaneous ulcer of the colon associated Hodgkin lymphoma in Crohn's disease.

Authors:  Neil R Moran; Bradley Webster; Kenneth M Lee; Judith Trotman; Yiu-Lam Kwan; John Napoli; Rupert W Leong
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

6.  Pattern analysis of Epstein-Barr virus viremia and its significance in the evaluation of organ transplant patients suspected of having posttransplant lymphoproliferative disorders.

Authors:  Young-Uk Cho; Hyun-Sook Chi; Seongsoo Jang; Sang Hyuk Park; Chan-Jeoung Park
Journal:  Am J Clin Pathol       Date:  2014-02       Impact factor: 2.493

Review 7.  Oral posttransplantation lymphoproliferative disorder: an uncommon site for an uncommon disorder.

Authors:  Sharon Elad; Cyril Meyerowitz; Michael Y Shapira; Michael Glick; Menachem Bitan; Gail Amir
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2008-01

8.  Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation.

Authors:  Ola Landgren; Ethel S Gilbert; J Douglas Rizzo; Gérard Socié; Peter M Banks; Kathleen A Sobocinski; Mary M Horowitz; Elaine S Jaffe; Douglas W Kingma; Lois B Travis; Mary E Flowers; Paul J Martin; H Joachim Deeg; Rochelle E Curtis
Journal:  Blood       Date:  2009-03-05       Impact factor: 22.113

9.  EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.

Authors:  Melissa Hart; Beenu Thakral; Sophia Yohe; Henry H Balfour; Charanjeet Singh; Michael Spears; Robert W McKenna
Journal:  Am J Surg Pathol       Date:  2014-11       Impact factor: 6.394
  9 in total
  7 in total

Review 1.  [Aggressive primary cutaneous B-cell lymphomas and novel EBV+ entities].

Authors:  C Lamos; E Dippel
Journal:  Hautarzt       Date:  2017-09       Impact factor: 0.751

2.  Epstein-Barr virus-related lymphoproliferative disorders in T-cell repleted haploidentical transplantation with post-transplant cyclophosphamide.

Authors:  Vedat Uygun; Nazan Özsan; Hayriye Daloğlu; Seda Öztürkmen; Koray Yalçın; Gülsün Karasu; Akif Yeşilipek
Journal:  Int J Hematol       Date:  2021-11-26       Impact factor: 2.490

Review 3.  New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders.

Authors:  Leticia Quintanilla-Martinez; Steven H Swerdlow; Thomas Tousseyn; Carlos Barrionuevo; Shigeo Nakamura; Elaine S Jaffe
Journal:  Virchows Arch       Date:  2022-10-11       Impact factor: 4.535

4.  Mucocutaneous ulcer: a mimic of EBV + diffuse large B cell lymphoma in the immunodeficiency setting.

Authors:  Dita Gratzinger; Elaine S Jaffe
Journal:  Leuk Lymphoma       Date:  2016-04-13

5.  Epstein-Barr Virus-related mucocutaneous ulcer lymphoma associated with Crohn's disease, treated with monoclonal antibody anti-CD30.

Authors:  Lydia Montes; Estelle Tredez; Clara Yzet; Caroline Delette; Denis Chatelain; Delphine Lebon; Mathurin Fumery; Jean-Pierre Marolleau
Journal:  Clin Case Rep       Date:  2020-04-08

6.  Epstein-Barr virus mucocutaneous ulcer followed by Hodgkin lymphoma in multiple myeloma patient.

Authors:  Moriah Forster; Yuri Fedoriw; Sascha Tuchman; Natalie Grover
Journal:  Clin Case Rep       Date:  2022-03-03

Review 7.  Co-Occurrence of EBV-Positive Mucocutaneous Ulcer (EBV-MCU) and CLL/SLL in the Head and Neck Region.

Authors:  Patricia Bott; Ilske Oschlies; Andreas Radeloff; Maureen Loewenthal
Journal:  Curr Oncol       Date:  2022-04-15       Impact factor: 3.109
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.